Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Louisiana State University System · Pennington Biomedical Research Center · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,011
total citations
- FWCI
- 36.88
- Percentile
- 100%
- References
- 34
Citations per year
Authors
8- FLFrank L. GreenwayCorresponding
Louisiana State University System, Pennington Biomedical Research Center
- KFKen Fujioka
Scripps Clinic
- RARaymond A Plodkowski
VA Sierra Nevada Health Care System, University of Nevada, Reno
- SMSunder Mudaliar
University of California, San Diego, VA San Diego Healthcare System
- MGMaria Guttadauria
Topics & keywords
Topics
Keywords
- Medicine
- Placebo
- Bupropion
- Overweight
- Naltrexone
- Body mass index
- Obesity
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.